Platelet Receptor Inhibitors:阻害薬のグローバル市場2014(薬開発、治験動向)

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIMR2014567)
◆英語タイトル:Platelet Receptor Inhibitors -Pipeline Insights, 2014
◆発行会社/調査会社:DelveInsight
◆商品コード:DIMR2014567
◆発行日:2014年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:25以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥135,000見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[Platelet Receptor Inhibitors:阻害薬のグローバル市場2014(薬開発、治験動向)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

DelveInsight’s,“Platelet Receptor Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Platelet Receptor Inhibitors. This report provides information on the therapeutic development based on the Platelet Receptor Inhibitors dealing with mechanism of action, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated mechanism of action.


• The report provides a snapshot of the global therapeutic landscape of Platelet Receptor Inhibitors
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Platelet Receptor Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Platelet Receptor Inhibitors and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

• Complete MOA intelligence and complete understanding over therapeutics development for Platelet Receptor Inhibitors
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
• Devise corrective measures for pipeline projects by understanding Platelet Receptor Inhibitors pipeline depth and focus of Indication therapeutics
• Developing strategic initiatives to support your drug development activities.
• Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
• Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
• Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

*** レポート目次(コンテンツ)***

• Platelet Receptor Inhibitors Overview
• Platelet Receptor Inhibitors Disease Associated
• Platelet Receptor Inhibitors Pipeline Therapeutics
• Platelet Receptor Inhibitors Therapeutics under Development by Companies
• Platelet Receptor Inhibitors Late Stage Products (Filed and Phase III)
• Comparative Analysis
• Platelet Receptor Inhibitors Mid Clinical Stage Products (Phase II)
• Comparative Analysis
• Platelet Receptor Inhibitors Early Clinical Stage Products (Phase I and IND Filed)
• Comparative Analysis
• Platelet Receptor Inhibitors Discovery and Pre-Clinical Stage Products
• Comparative Analysis
• Drug Candidate Profiles
• Platelet Receptor Inhibitors – Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• Platelet Receptor Inhibitors – Discontinued Products
• Platelet Receptor Inhibitors – Dormant Products
• Companies Involved in Therapeutics Development for Platelet Receptor Inhibitors
• Appendix
• Methodology
• Contact Us
• Disclaimer

• Number of Products under Development for Platelet Receptor Inhibitors by Therapy Area, 2014
• Number of Products under Development for Platelet Receptor Inhibitors, 2014
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
• Drug Candidates Profiles
• Platelet Receptor Inhibitors Assessment by Monotherapy Products
• Platelet Receptor Inhibitors Assessment by Combination Products
• Platelet Receptor Inhibitors Assessment by Route of Administration
• Platelet Receptor Inhibitors Assessment by Stage and Route of Administration
• Platelet Receptor Inhibitors Assessment by Molecule Type
• Platelet Receptor Inhibitors Assessment by Stage and Molecule Type
• Platelet Receptor Inhibitors Therapeutics – Discontinued Products
• Platelet Receptor Inhibitors Therapeutics – Dormant Products
• Products under Development by Companies, 2014

• Number of Products under Development for Platelet Receptor Inhibitors by Therapy Area, 2014
• Number of Products under Development for Platelet Receptor Inhibitors, 2014
• Late Clinical Stage Products (Filed and Phase III), 2014
• Mid Clinical Stage Products (Phase II), 2014
• Early Clinical Stage Products (Phase I and IND Filed), 2014
• Discovery and Pre-Clinical Stage Products, 2014
• Platelet Receptor Inhibitors Assessment by Monotherapy Products
• Platelet Receptor Inhibitors Assessment by Combination Products
• Platelet Receptor Inhibitors Assessment by Route of Administration
• Platelet Receptor Inhibitors Assessment by Stage and Route of Administration
• Platelet Receptor Inhibitors Assessment by Molecule Type
• Platelet Receptor Inhibitors Assessment by Stage and Molecule Type

*** レポートのキーワード ***

薬剤、医薬品、製薬企業、試験、作用機序(MOA)、パイプライン、開発

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 世界及び中国のシュウ酸カリウム市場2016
    The 'Global and Chinese Potassium oxalate Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Potassium oxalate industry with a focus on the Chinese market. The report provides key statistics on the market status of the Potassium oxalat …
  • スピリッツ(蒸留酒)市場の展望(~2018):ハンガリー
    Summary - This report provides authoritative and granular detail of the Spirits market in Hungary; and in doing so fills the gaps in marketers' understanding of market trends and the components of change causing them. - Based upon extensive secondary research, this report provides comprehensive and …
  • 世界のラセミ体レパグリニド市場2017
    Racemic Repaglinide Market Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United Sta …
  • OceanaGold Corporation (OGC):企業概要及びSWOT分析
    World Market Intelligence's "OceanaGold Corporation (OGC) - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company hi …
  • インドの産業用ギヤボックス・ギヤモータ市場2016:市場規模、シェア、動向、予測
    This report provides an insight into the Opportunity in Industrial Gear Box and Gear Motors current market scenario, structure and practices in India. In depth market scenario includes; - Current market size estimates, including domestic market, imports and exports - Market size by players – Top Com …
  • 炭酸鉛の世界市場2019
    The Global Leadcarbonate (CAS 598-63-0) Industry 2019 Market Research Report is a professional and in-depth study on the current state of the Leadcarbonate industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain …
  • 世界及び中国のリマンタジン市場2015
    The 'Global and Chinese Rimantadine Industry, 2010-2020 Market Research Report' is a professional and in-depth study on the current state of the global Rimantadine industry with a focus on the Chinese market. The report provides key statistics on the market status of the Rimantadine manufacturers an …
  • Indolent Lymphoma:治療薬パイプラインレビュー(2014年上半期)
    Indolent Lymphoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Indolent Lymphoma - Pipeline Review, H1 2014’, provides an overview of the Indolent Lymphoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Indolent Lymphoma, com …
  • 婦人用ランニングシューズの世界市場:販売動向2017
    Notes:Sales, means the sales volume of Women's Running Shoes Revenue, means the sales value of Women's Running Shoes This report studies sales (consumption) of Women's Running Shoes in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countr …
  • ラックマウントKVMスイッチの世界市場2016
    The Global Rackmount KVM Switch Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Rackmount KVM Switch industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain s …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIMR2014567 )"Platelet Receptor Inhibitors:阻害薬のグローバル市場2014(薬開発、治験動向)" (英文:Platelet Receptor Inhibitors -Pipeline Insights, 2014)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。